Skip to main content
PMC home page
Heart logoLink to Heart
. 1998 Mar;79(3):248–252. doi: 10.1136/hrt.79.3.248

Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies

J Yarnell 1, C Patterson 1, D Bainton 1, P Sweetnam 1
PMCID: PMC1728632  PMID: 9602657

Abstract

Objective—To examine the clinical and epidemiological utility of the concepts of metabolic syndrome and insulin resistance syndrome in two prospective cohort studies of white men.
Methods—Men aged 45-63 years were screened for evidence of ischaemic heart disease (IHD) between 1979 and 1982 and followed up at regular intervals thereafter. Non-fatal coronary events were validated from hospital records and fatal coronary events from death certificates.
Results—Analysis of serum insulin concentrations in non-diabetic individuals measured at entry to the study showed no independent contribution to the prediction of subsequent IHD at 10 year follow up. Blood glucose concentrations, however, showed a small independent contribution in the combined cohort in the upper fifth of the distribution. Three different models of metabolic syndrome among non-diabetic individuals were defined based on tertiles, medians, and clusters. The predictive value of each model was assessed using logistic regression before and after adjustment for conventional and metabolic risk factors. After adjustment the odds were non-significant and close to unity.
Conclusions—This study did not detect any complex relation among the five variables defining metabolic syndrome; the excess risk seems to be no greater than can be explained by individual effects of the defining variables in a multiple logistic model.

 Keywords: metabolic syndrome;  insulin resistance;  screening;  ischaemic heart disease;  epidemiology

Full Text

The Full Text of this article is available as a PDF (117.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bainton D., Miller N. E., Bolton C. H., Yarnell J. W., Sweetnam P. M., Baker I. A., Lewis B., Elwood P. C. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J. 1992 Jul;68(1):60–66. doi: 10.1136/hrt.68.7.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bao W., Srinivasan S. R., Berenson G. S. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 1996 Jan 1;93(1):54–59. doi: 10.1161/01.cir.93.1.54. [DOI] [PubMed] [Google Scholar]
  3. Cullen K., Stenhouse N. S., Wearne K. L., Welborn T. A. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study. J Chronic Dis. 1983;36(5):371–377. doi: 10.1016/0021-9681(83)90169-8. [DOI] [PubMed] [Google Scholar]
  4. DeFronzo R. A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991 Mar;14(3):173–194. doi: 10.2337/diacare.14.3.173. [DOI] [PubMed] [Google Scholar]
  5. Després J. P., Lamarche B., Mauriège P., Cantin B., Dagenais G. R., Moorjani S., Lupien P. J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996 Apr 11;334(15):952–957. doi: 10.1056/NEJM199604113341504. [DOI] [PubMed] [Google Scholar]
  6. Ducimetiere P., Eschwege E., Papoz L., Richard J. L., Claude J. R., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980 Sep;19(3):205–210. doi: 10.1007/BF00275270. [DOI] [PubMed] [Google Scholar]
  7. Duncan M. H., Singh B. M., Wise P. H., Carter G., Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet. 1995 Jul 8;346(8967):120–121. doi: 10.1016/s0140-6736(95)92143-5. [DOI] [PubMed] [Google Scholar]
  8. ELWOOD P. C., JACOBS A., PITMAN R. G., ENTWISTLE C. C. EPIDEMIOLOGY OF THE PATERSON-KELLY SYNDROME. Lancet. 1964 Oct 3;2(7362):716–720. doi: 10.1016/s0140-6736(64)92541-3. [DOI] [PubMed] [Google Scholar]
  9. Ferrannini E., Haffner S. M., Mitchell B. D., Stern M. P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991 Jun;34(6):416–422. doi: 10.1007/BF00403180. [DOI] [PubMed] [Google Scholar]
  10. Ferrara A., Barrett-Connor E. L., Edelstein S. L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol. 1994 Nov 15;140(10):857–869. doi: 10.1093/oxfordjournals.aje.a117174. [DOI] [PubMed] [Google Scholar]
  11. Fontbonne A. M., Eschwège E. M. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 1991 Jun;14(6):461–469. doi: 10.2337/diacare.14.6.461. [DOI] [PubMed] [Google Scholar]
  12. Fontbonne A., Charles M. A., Thibult N., Richard J. L., Claude J. R., Warnet J. M., Rosselin G. E., Eschwège E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991 May;34(5):356–361. doi: 10.1007/BF00405009. [DOI] [PubMed] [Google Scholar]
  13. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hargreaves A. D., Logan R. L., Elton R. A., Buchanan K. D., Oliver M. F., Riemersma R. A. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992 May;94(1):61–69. doi: 10.1016/0021-9150(92)90188-m. [DOI] [PubMed] [Google Scholar]
  15. Kaplan N. M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989 Jul;149(7):1514–1520. doi: 10.1001/archinte.149.7.1514. [DOI] [PubMed] [Google Scholar]
  16. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993 May 1;137(9):959–965. doi: 10.1093/oxfordjournals.aje.a116768. [DOI] [PubMed] [Google Scholar]
  17. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985 Mar;75(3):809–817. doi: 10.1172/JCI111776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Orchard T. J., Eichner J., Kuller L. H., Becker D. J., McCallum L. M., Grandits G. A. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994 Jan;4(1):40–45. doi: 10.1016/1047-2797(94)90041-8. [DOI] [PubMed] [Google Scholar]
  19. Perry I. J., Wannamethee S. G., Whincup P. H., Shaper A. G., Walker M. K., Alberti K. G. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol. 1996 Aug 1;144(3):224–234. doi: 10.1093/oxfordjournals.aje.a008917. [DOI] [PubMed] [Google Scholar]
  20. Pyöräla K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979 Mar-Apr;2(2):131–141. doi: 10.2337/diacare.2.2.131. [DOI] [PubMed] [Google Scholar]
  21. Pyörälä K., Savolainen E., Kaukola S., Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl. 1985;701:38–52. doi: 10.1111/j.0954-6820.1985.tb08888.x. [DOI] [PubMed] [Google Scholar]
  22. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  23. Reaven G. M. Syndrome X: 6 years later. J Intern Med Suppl. 1994;736:13–22. [PubMed] [Google Scholar]
  24. Rose G., Hamilton P. S., Keen H., Reid D. D., McCartney P., Jarrett R. J. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet. 1977 Jan 15;1(8003):105–109. doi: 10.1016/s0140-6736(77)91701-9. [DOI] [PubMed] [Google Scholar]
  25. Rudenski A. S., Matthews D. R., Levy J. C., Turner R. C. Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes. Metabolism. 1991 Sep;40(9):908–917. doi: 10.1016/0026-0495(91)90065-5. [DOI] [PubMed] [Google Scholar]
  26. Welborn T. A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979 Mar-Apr;2(2):154–160. doi: 10.2337/diacare.2.2.154. [DOI] [PubMed] [Google Scholar]
  27. Welin L., Eriksson H., Larsson B., Ohlson L. O., Svärdsudd K., Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men. The study of men born in 1913. Diabetologia. 1992 Aug;35(8):766–770. doi: 10.1007/BF00429098. [DOI] [PubMed] [Google Scholar]
  28. Wiener K. Fasting plasma glucose as a screening test for diabetes mellitus. Diabet Med. 1997 Aug;14(8):711–712. doi: 10.1002/(sici)1096-9136(199708)14:8<711::aid-dia430>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  29. Williams B. Insulin resistance: the shape of things to come. Lancet. 1994 Aug 20;344(8921):521–524. doi: 10.1016/s0140-6736(94)91904-6. [DOI] [PubMed] [Google Scholar]
  30. Yarnell J. W., Patterson C. C., Sweetnam P. M. Simple measure of insulin resistance. Lancet. 1995 Oct 21;346(8982):1108–1109. doi: 10.1016/s0140-6736(95)91786-1. [DOI] [PubMed] [Google Scholar]
  31. Yarnell J. W., Pickering J. E., Elwood P. C., Baker I. A., Bainton D., Dawkins C., Phillips D. I. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol. 1994 Apr;47(4):383–388. doi: 10.1016/0895-4356(94)90159-7. [DOI] [PubMed] [Google Scholar]
  32. Yarnell J. W., Sweetnam P. M., Marks V., Teale J. D., Bolton C. H. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J. 1994 Mar;71(3):293–296. doi: 10.1136/hrt.71.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. de Courten M., Zimmet P. Screening for non-insulin-dependent diabetes mellitus: where to draw the line? Diabet Med. 1997 Feb;14(2):95–98. doi: 10.1002/(SICI)1096-9136(199702)14:2<95::AID-DIA333>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES